Dalmia Bharat Refractories LimitedUnlisted Shares
₹ 215▼12.24%(30.00)
About the company
Dalmia Bharat Refractories Limited (DBRL) is one of India's leading refractory solutions companies, serving core industries that operate in high-temperature environments, including steel, cement, non-ferrous metals, glass, and other process industries. The company offers a comprehensive range of refractory products and technical solutions that help improve operational efficiency, equipment life, and plant performance.
DBRL was formed through the strategic amalgamation of Dalmia Refractory Limited, GSB Refractory, and SDMM Refractory, bringing together the strengths, expertise, and capabilities of these businesses under a single, unified organization. This consolidation was undertaken to build a stronger and more competitive company with enhanced financial strength, greater investment capacity, and a broader talent pool. By combining resources, DBRL is well-positioned to serve customers with innovative products, reliable services, and long-term technical support.
Fundamentals
Valuation
- 52 week high
- ₹255
- 52 week low
- ₹215
- P/B ratio
- 4.25
- Debt to equity
- 4.28
- ROE (%)
- -100.37%
- Book value
- ₹50.61
- Face value
- ₹10
- Valuation
- —
Registry
- ISIN number
- INE0EB001012
Figures in cr ·
Financials
| P&L Statement | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Revenue | 790 | 300 | 346 | 116 | 106 | 267 |
| EBITDA | 56 | 46 | 25 | -28 | -20 | -124.5 |
| OPM | 7.09 | 15.33 | 7.23 | -24.14 | -18.87 | -46.44 |
| PBT | -3 | 35 | 1749 | 56 | -37 | -223 |
| PAT | -4 | 23 | 1335 | 47 | -37 | -223 |
| EPS | -571.43 | 5.2 | 302.04 | 10.63 | -8.37 | -48.61 |
Shareholding Pattern
Leadership
| Name | Role | Experience | |
|---|---|---|---|
| C. N. Maheshwari | CEO | 20+ yrs experience | |
| Raj Kamal Saraogi | Director | 20+ yrs experience | — |
| Rahul Sahni | CFO | 20+ yrs experience | — |
Frequently asked questions
Common questions on Dalmia Bharat Refractories Limited Unlisted Shares—tap a row to read the answer.
Q.1What are Dalmia Bharat Refractories Limited unlisted shares?
Dalmia Bharat Refractories Limited unlisted shares are equity shares of the company that are not traded on recognized stock exchanges such as the NSE or BSE. These shares are bought and sold through private, off-market transactions and are typically held by investors seeking exposure to established businesses before any potential public listing.
Q.2How can I buy Dalmia Bharat Refractories Limited unlisted shares?
To buy Dalmia Bharat Refractories Limited unlisted shares, you need an active demat account and must complete the required KYC formalities. Once a seller is identified and the transaction terms are agreed upon, the shares are transferred to your demat account through an off-market transfer. Before investing, it is advisable to verify the latest share price, share availability, and transaction details.
Q.3Can I sell Dalmia Bharat Refractories Limited unlisted shares before a public listing?
Yes. You can sell your Dalmia Bharat Refractories Limited unlisted shares at any time, provided a buyer is available in the unlisted market. Since these shares are not exchange-traded, liquidity depends on market demand, and the time required to complete a sale may vary.
Q.4How is the price of Dalmia Bharat Refractories Limited unlisted shares determined?
The value of unlisted shares is influenced by several factors, including the company's financial performance, revenue and profitability, business expansion plans, industry outlook, demand and supply in the private market, and recent off-market transactions. Because there is no live exchange price, valuations may differ between transactions.
Q.5What factors should I evaluate before investing in Dalmia Bharat Refractories Limited unlisted shares?
Before investing, consider reviewing the company's financial statements, profitability, debt position, management quality, market presence, future growth strategy, and the outlook for the refractory industry. It is also important to understand the risks associated with investing in unlisted companies and ensure the investment aligns with your financial objectives.
Trending shares
High-demand unlisted opportunities currently available for trade.
From the blog
Notes on unlisted markets, execution hygiene, and how we think about risk—no hype, no ticker spam.

APTUS PHARMA IPO
Aptus Pharma Limited rolled out its 100% book-built BSE SME public offering worth ₹13.02 Crore. Review crucial parameters for retail investors, featuring the ₹65–₹70 price band, working capital allocations, and an evaluation of its contract-manufacturing partner model.

NEPHROPLUS (NEPHROCARE HEALTH SERVICES) IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

APOLLO TECHNO INDUSTRIES IPO
Apollo Techno Industries Limited has announced its public offering details. Explore the essential investment parameters for retail and institutional bidders, highlighting the fixed price band, lot structure, key market deadlines, and an overview of its industrial manufacturing footprint.

NEOCHEM BIO IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

ANONDITA MEDICARE IPO
Anondita Medicare Limited rolled out its 100% book-built SME public offering worth ₹69.50 Crore on the NSE SME platform. Dig into the critical parameters for investors, highlighting the ₹137–₹145 price band, key working capital objectives, and an analysis of its flagship brand 'COBRA' within the growing sexual wellness market.

NEPTUNE LOGITEK IPO
Explore the Neptune Logitek IPO, including issue details, business strengths, risks, and investment analysis.
